The Ethical, Legal, and Social Implications Program of the National Human Genome Research Institute: Reflections on an Ongoing Experiment
- 31 August 2014
- journal article
- review article
- Published by Annual Reviews in Annual Review of Genomics and Human Genetics
- Vol. 15 (1), 481-505
- https://doi.org/10.1146/annurev-genom-090413-025327
Abstract
For more than 20 years, the Ethical, Legal, and Social Implications (ELSI) Program of the National Human Genome Research Institute has supported empirical and conceptual research to anticipate and address the ethical, legal, and social implications of genomics. As a component of the agency that funds much of the underlying science, the program has always been an experiment. The ever-expanding number of issues the program addresses and the relatively low level of commitment on the part of other funding agencies to support such research make setting priorities especially challenging. Program-supported studies have had a significant impact on the conduct of genomics research, the implementation of genomic medicine, and broader public policies. The program's influence is likely to grow as ELSI research, genomics research, and policy development activities become increasingly integrated. Achieving the benefits of increased integration while preserving the autonomy, objectivity, and intellectual independence of ELSI investigators presents ongoing challenges and new opportunities.Keywords
This publication has 70 references indexed in Scilit:
- Funding and Forums for ELSI Research: Who (or What) Is Setting the Agenda?AJOB Primary Research, 2012
- Informed consent for whole genome sequencing: A qualitative analysis of participant expectations and perceptions of risks, benefits, and harmsAmerican Journal of Medical Genetics Part A, 2012
- Research Guidelines in the Era of Large-scale Collaborations: An Analysis of Genome-wide Association Study ConsortiaAmerican Journal of Epidemiology, 2012
- Swabbing Students: Should Universities Be Allowed to Facilitate Educational DNA Testing?American Journal of Bioethics, 2012
- Identifiability in biobanks: models, measures, and mitigation strategiesHuman Genetics, 2011
- Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease RiskThe New England Journal of Medicine, 2011
- Public Opinion about the Importance of Privacy in Biobank ResearchAmerican Journal of Human Genetics, 2009
- Disclosure ofAPOEGenotype for Risk of Alzheimer's DiseaseThe New England Journal of Medicine, 2009
- Identifiability of DNA Data: The Need for Consistent Federal PolicyAmerican Journal of Bioethics, 2008
- Information Needs of Mothers Regarding CommunicatingBRCA1/2Cancer Genetic Test Results to Their ChildrenGenetic Testing, 2007